Upload
others
View
2
Download
0
Embed Size (px)
Citation preview
Product by Process Claim
Abstract
A product by process claim may be defined as one in which the productis defined, at least in part, in terms of the process by which it is produced. These
are claims reciting a product by the process by which it was made, rather than by
its structure or properties. Such claims may be obtained whenever the product has
novelty and inventive step over prior art products.
A product by process claim is generally construed as not limited to a product
produced by the recited process but a product itself regardless of its process of
production, in prosecution of applications as well as in patent infringement
litigation. However, practical difficulties are involved in establishing the
infringement when the accused product is produced by a different process from
the recited process.
92.3 51 13
,
14 51 92.3
Keywords product by process claim, prima facie identical, obtainable,
Chinese herbal medicine
Product by Process
1
92.3 51 15
1.2000 28,451 , 21,621 , 76.0% 2001
33,392 , 24,222 , 72.5% 2002 31,616 ,
21,982 , 69.5%
16 51 92.3
2001 10 24 2002
11 6 2003 1 3
20022
WIPO
Patent Law Treaty
1877 Smith v.
Goodyear Dental Vulcanite Co. Merrill v. Yeomans 3
1972 (Federal Supreme Court) Trioxan4
1
2. 2002 12 123.Smith v. Goodyear Dental Vulcanite Co.,93 U.S 486,499(1877);Merrill v. Yeomans,94
U.S.568,571(1877)
4. Trioxan X ZB 9/70 of 6.7.1971,GRUR 1972,80(IIC 1972,226)
2
3
( )5
1984 EPO Claim categories / IEF 6
:
1
27
1.
8
method or process
92.3 51 17
5.Bernd Hansen & Fritjoff Hirsch, Protection Inventions in Chemistry ,p.74 1997
6. Claim categories / IEF T 150/82 of 7.2.1984,OJ 1984,309
7. 5
8.Robert C .Faber, Landis on Mechanics of Patent Claim Drafting ,3rd ed.,p.134, March,1990
9.Harold C. Wegner, Patent Law in Biotechnology ,Chemicals & Pharmaceuticals , 283 p.362
1994
18 51 92.3
9
2.(1)
(2)
(3) (
)
(1)
(2)
(2) (3)
( )10 A B C
( )
(a) (b)
(c) .
(a) (b) (c)
10. comprising including containing characterized by consisting
of consisting essentially of
nature
3.11
92.3 51 19
11. Irah H. Donner, Patent Prosecution ,2nd ed.p.584(1999) E.P.Mirabel ,Product-by-
Process Claims :A Practical Perspective,68 JOUR.PAT.& TRADEMARK OFF.SOC Y 3(1986)
, , 1 ,
, 2 , 3
,12.Atlantic Thermoplastics Co. Inc. v. Faytex Corp.,974 F.2d 1299,24 USPQ 2d 1138
Fed.Cir.1992 ,on denial of suggestion for en banc rehearing,970 F. 2d 834,23 USPQ 2d 1481
Fed.Cir.1992 Atlantic Thermoplastics U.S. Patent No.4,674,204 204 patent
1
, 24
1 ,
,
, polyurethane
Atlantic Faytex Surge Sorbothane
, Faytex Surge
, Sorbothane Sorbothane
, , ,
, ,Faytex
24 ,
1 , Atlantic
Scripps Clinic & Research Foundation. v. Genentec Inc. , Sorbothane
20 51 92.3
Atlantic Thermoplastics Co. Inc. v. Faytex Corp. 12
1
6
1
VIII:C
structural limitation process limitation
CAFC13
(CCPA)
In re Johnson 14
Atlantic Thermoplastics Co. Inc. v. Faytex Corp.
.
Surge , Sorbothane
, Atlantic
,
, ,
Atlantic , Sorbothane
13.Fromson. v. Advance Offset Plate, Inc.,720 F.2d 1565,219 USPQ 1137,1141(Fed.Cir.1983)
14.In re Johnson,394 F.2d 591,157 USPQ 620(CCPA.1968)
15.In re Moore,439 F.2d 1232,169 USPQ 236,239(CCPA.1971)
In re Moore 15
1 alkyladamantane
(composition of matter)
CCPA
.
.
Moore
CCPA
CCPA In re Garnero16
1
CCPA
CCPA
92.3 51 21
16.In re Garnero,412 F.2d 276,162 USPQ 221,223(CCPA.1969)
22 51 92.3
CCPA
1.
2.
3.
92.3 51 23
17.Harold C. Wegner, Patent Law in Biotechnology ,Chemicals & Pharmaceuticals ,
281,p.353(1994)
24 51 92.3
.18
. 19 fingerprint claim
.
.
1994 1 1
EPO A
B obtainable
18.
,
,
19. , ,
, , , , ,
obtained
A obtainable A
1.1974 4 CCPA
( ) MPEP 706.03(e)
(MPEP) 706.03(e) 22
92.3 51 25
20 In re Johnson,394 F.2d 591,594,157 USPQ 620,623(CCPA 1968) In re Lifton,189 F2d 261,89
USPQ 641(CCPA 1951) In re Mckee,95 F2d 264,266,37 USPQ 209,210(CCPA 1938)
21. 1891 In re Painter,57 Off .Gaz . Pat. Office 999(1891)
,
, , ,
22. Harold C. Wegner, Patent Law in Biotechnology ,Chemicals & Pharmaceuticals , 280 p.351
1994
26 51 92.3
( ) (MPEP)
Leutzinger v. Ladd23
1 200
4 9 1
CCPA
1969
112
Hughes 24 CCPA
1974 4
25
23.139 U.S.P.Q.(BNA)196(D.D.C.1963)
24. Hughes,496 F.2d 1216,1219,182 USPQ 106,108(CCPA 1974)
25. Ex parte Hartman,186 U.S.P.Q.(BNA) 336(Bd.App.1974)
26. MANUAL OF PATENT EXAMINATION PROCEDURE ,2173.05(p),Eighth Edition,2001,8
( ) (MPEP)26
112
1992
Atlantic Thermoplastics Co. Inc. v. Faytex Corp.27
backup 28
2.1994 36
1995 7 129
1
92.3 51 27
27.Irah H. Donner, Patent Prosecution ,2nd ed.p.50(1999)
28.Martin J. Adelman ,Randall R. Rader, John R. Thomas ,Harold C. Wegner , CASES AND
MATERIALS ON PATENT LAW ,p.647(1998)
29. ,P.6-7,1975,10
28 51 92.3
2
1
2
1994 2001
30
1995 7 1
3.2001 31
30. 36 (6)(ii) ,
31. Guidelines for Examination in the European Patent Office ,Part C ,Chapter 4.7b(2001)
32. T 150/82,OJ 7/1984,309
33. producible , 15W (pat) 72/81 of 15.6.1983,BPatGE 25,202
34.2001 10 18 3.3 ,p.2-159
32
Y obtainable
X 33 Y obtained X
4.2001 34 35
5.1988 8 36
1994 11 25 37
92.3 51 29
35. , 1993 3 10 ,p.358
36. ,
37. ,p.1-3-16
38. (1)
M3827 3(ATCC No.CRL 9193) 2
, 3 0.1M
, 25,000 4
, 5 ,
(6) ,
10,000
30 51 92.3
14013538
1995 7 1
140135
2002
1.
. A B
.
2.
-
Al2O3 .
.
3.
.
C
.
39
92.3 51 31
39.2001 10 18 8(8) (p.1-41)
32 51 92.3
1
2
1.
2. 1 2
40 41
EPO Y
obtained X Y obtainable
producible X
T 411/89
42
40. 22 3
41. , , ,1996 4
42. , , ,p.302,
2001
1995 7 1
1995 7 1
92.3 51 33